NCT05692726 Evaluation of Volume and Electrolyte Balance in Hyponatremia Treatment - a Prospective Observational Trial
| NCT ID | NCT05692726 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Cologne |
| Condition | Non-hypervolemic Hyponatremia |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2022-10-15 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2022-10-15 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To assess quantitatively the evolution over time of electrolyte-free water clearance and electrolyte mass balance in patients with non-hypervolemic hypotonic hyponatremia
Eligibility Criteria
Inclusion Criteria: * Adult patients ≥ 18 years * Hypotonic hyponatremia * glucose-corrected plasma sodium \<130 mmol/l * serum osmolality \<280 mosmol/kg or lack of signs of non-hypotonic hyponatremia Exclusion Criteria: * Signs of extracellular volume expansion * Patients with liver cirrhosis and severe liver damage AST/ALT\>3xULN, AP\>6xULN, Bilirubin ≥ 3mg/dl * Patients with heart failure * Patients on dialysis and/or patients with oliguric renal impairment and plasma creatinine ≥ 3mg/dl * Patients after organ transplantation
Contact & Investigator
Volker Burst, MD, Prof.
PRINCIPAL INVESTIGATOR
University Hospital of Cologne
Frequently Asked Questions
Who can join the NCT05692726 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Non-hypervolemic Hyponatremia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05692726 currently recruiting?
Yes, NCT05692726 is actively recruiting participants. Contact the research team at volker.burst@uk-koeln.de for enrollment information.
Where is the NCT05692726 trial being conducted?
This trial is being conducted at Cologne, Germany.
Who is sponsoring the NCT05692726 clinical trial?
NCT05692726 is sponsored by University of Cologne. The principal investigator is Volker Burst, MD, Prof. at University Hospital of Cologne. The trial plans to enroll 50 participants.